Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma

Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma remains one of the most aggressive cancers with an ongoing dismal survival rate despite some recent advances in treatment options. This is largely due to the typically late presentation and limited effective therapeutic options in advanced disease. There are numerous circul...

Full description

Bibliographic Details
Main Authors: Matthew Loft, Belinda Lee, Jeanne Tie, Peter Gibbs
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Journal of Personalized Medicine
Subjects:
pancreatic cancer
circulating tumour DNA (ctDNA), biomarkers
liquid biopsy
personalised oncology
targeted therapy
intratumoural heterogeneity
molecular resistance
Online Access:https://www.mdpi.com/2075-4426/9/3/37

Internet

https://www.mdpi.com/2075-4426/9/3/37

Similar Items